Kohei Teraoka

427 total citations
17 papers, 353 citations indexed

About

Kohei Teraoka is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kohei Teraoka has authored 17 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kohei Teraoka's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Viral Infections and Immunology Research (8 papers) and Receptor Mechanisms and Signaling (4 papers). Kohei Teraoka is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Viral Infections and Immunology Research (8 papers) and Receptor Mechanisms and Signaling (4 papers). Kohei Teraoka collaborates with scholars based in Japan, Sweden and Sri Lanka. Kohei Teraoka's co-authors include Noboru Takekoshi, Shinobu Matsui, Shogo Katsuda, Takayuki Kurihara, Michael Fu, Nobuo Yamaguchi, Eiji Murakami, Åke Hjalmarson, Johan Hoebeke and Michael Fu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Chromatography A and Journal of Molecular and Cellular Cardiology.

In The Last Decade

Kohei Teraoka

17 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kohei Teraoka Japan 10 238 155 134 37 28 17 353
Michael Fu Sweden 13 391 1.6× 259 1.7× 191 1.4× 63 1.7× 16 0.6× 28 552
Rita Garamvölgyi Hungary 10 90 0.4× 145 0.9× 28 0.2× 21 0.6× 13 0.5× 32 352
Jiqiang He China 10 138 0.6× 83 0.5× 70 0.5× 15 0.4× 6 0.2× 38 309
Adam J. Guenzel United States 10 91 0.4× 240 1.5× 23 0.2× 11 0.3× 13 0.5× 15 347
A. Audet Canada 10 298 1.3× 110 0.7× 30 0.2× 23 0.6× 25 0.9× 11 440
Khiem Nguyen United States 11 159 0.7× 132 0.9× 53 0.4× 71 1.9× 19 0.7× 19 433
Xinran Zhao China 9 95 0.4× 154 1.0× 18 0.1× 28 0.8× 8 0.3× 31 331
Jianbo Li China 8 98 0.4× 194 1.3× 18 0.1× 14 0.4× 7 0.3× 13 310
Ariane Maleszka Germany 7 61 0.3× 153 1.0× 21 0.2× 12 0.3× 30 1.1× 12 250
Donna Peace United States 8 83 0.3× 70 0.5× 82 0.6× 166 4.5× 10 0.4× 9 406

Countries citing papers authored by Kohei Teraoka

Since Specialization
Citations

This map shows the geographic impact of Kohei Teraoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Teraoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Teraoka more than expected).

Fields of papers citing papers by Kohei Teraoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Teraoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Teraoka. The network helps show where Kohei Teraoka may publish in the future.

Co-authorship network of co-authors of Kohei Teraoka

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Teraoka. A scholar is included among the top collaborators of Kohei Teraoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Teraoka. Kohei Teraoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Matsui, Shinobu, Lisa Larsson, Shogo Katsuda, et al.. (2006). Specific removal of β1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function. Journal of Molecular and Cellular Cardiology. 41(1). 78–85. 15 indexed citations
2.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (2005). Transfer of immune components from rabbit autoimmune cardiomyopathy into severe combined immunodeficiency (SCID) mice induces cardiomyopathic changes. Autoimmunity. 39(2). 121–128. 13 indexed citations
3.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (2003). Transfer of Rabbit Autoimmune Cardiomyopathy into Severe Combined Immunodeficiency Mice. Journal of Cardiovascular Pharmacology. 42. S99–S103. 21 indexed citations
4.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (2001). Beneficial Effect of Muscarinic-2 Antagonist on Dilated Cardiomyopathy Induced by Autoimmune Mechanism against Muscarinic-2 Receptor. Journal of Cardiovascular Pharmacology. 38. S43–S49. 11 indexed citations
5.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (2000). Beneficial Effect of Angiotensin-Converting Enzyme Inhibitor on Dilated Cardiomyopathy Induced by Autoimmune Mechanism Against β1-Adrenoceptor. Journal of Cardiovascular Pharmacology. 36. S43–S48. 1 indexed citations
6.
Matsui, Shinobu, Huamei Fu, Shogo Katsuda, et al.. (2000). Protective Effect of Bisoprolol on Beta-1 Adrenoceptor Peptide-Induced Autoimmune Myocardial Damage in Rabbits. Herz. 25(3). 267–270. 17 indexed citations
7.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (1999). Active immunization of combined β1-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits. Journal of Cardiac Failure. 5(3). 246–254. 32 indexed citations
8.
Teraoka, Kohei, et al.. (1999). [Na, K-ATPase on human red blood cell membranes].. PubMed. 57 Suppl. 784–8. 1 indexed citations
9.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (1997). Peptides Derived from Cardiovascular G-protein-coupled Receptors Induce Morphological Cardiomyopathic Changes in Immunized Rabbits. Journal of Molecular and Cellular Cardiology. 29(2). 641–655. 138 indexed citations
10.
Fu, Michael, et al.. (1995). Dilated Cardiomyopathy Defines Serum Autoantibodies Against G-Protein-Coupled Cardiovascular Receptors. Autoimmunity. 21(2). 85–88. 50 indexed citations
11.
Fujikawa‐Yamamoto, Kohzaburo, et al.. (1995). The important role of PKC in controlling polyploidy formation in cultured fibrosarcoma cell line.. PubMed. 35(5). 1009–15. 9 indexed citations
12.
Fujikawa‐Yamamoto, Kohzaburo, et al.. (1994). Potentiation of K252a, a Protein-Kinase Inhibitor-Induced Polyploidization by cAMP in Cultured Fibrosarcoma Cell Line. Biochemical and Biophysical Research Communications. 205(1). 746–750. 20 indexed citations
13.
Ishizaki, Masao, et al.. (1994). Erythrocyte Na+/K+-ATPase and Membrane and Serum Lipid Profiles: As Related to Alcohol, Body Mass Index and Blood Pressure. Clinical and Experimental Hypertension. 16(6). 741–759. 15 indexed citations
14.
Teraoka, Kohei, et al.. (1992). [Determination of human erythrocyte membrane Na+/K(+)-ATPase activity in small volume of blood sample].. PubMed. 40(4). 410–6. 1 indexed citations
15.
Takahashi, Naohiko, et al.. (1992). [A flow cytometric study of the effects of benzalkonium chloride on the cell cycle].. PubMed. 96(7). 823–7. 3 indexed citations
16.
Teraoka, Kohei, et al.. (1990). Pathophysiological function of the mitochondria as a calcium reservoir: Quantitative x-ray microanalysis. Proceedings annual meeting Electron Microscopy Society of America. 48(2). 164–165. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026